Therapeutics & Vaccines
Anti-Apoptotic Vector And Method Of Using The Same
WARF: P210046WO01
Inventors: Robert Nickells, Gillian McLellan, Ryan Donahue
The Invention
UW Madison researchers' present invention provides vectors for delivery of an anti-apoptotic therapy. The vectors include a phosphoglycerate kinase (Pgk) promoter operably connected to a polynucleotide encoding an anti-apoptotic BCL2 protein (e.g., BCLXL). The vectors may be 5 used in methods of treating conditions associated with apoptosis, including glaucoma.
Additional Information
For More Information About the Inventors
Tech Fields
For current licensing status, please contact Rafael Diaz at rdiaz@warf.org or 608-960-9847